MedPath

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF PARNAYAVANI (Coleus amboinicus Lour) PATRA ARKA NEBULIZATION IN THE MANAGEMENT OF TAMAKA SWASA W.S.R BRONCHIAL ASTHMA IN CHILDREN.

Phase 2
Conditions
Health Condition 1: J069- Acute upper respiratory infection,unspecifiedHealth Condition 2: J398- Other specified diseases of upperrespiratory tract
Registration Number
CTRI/2021/06/034036
Lead Sponsor
Sri Sri College of Ayurvedic science and Research Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Nebulization twice a day for a perod of 3 days(Dose: 2.5 ml arka for Nebulisation).

Children with mild to moderate exacerbation of asthma will be included.

Children in whom parents are willing to participate their child in the study and ready to sign the informed ascent form will be included.

Exclusion Criteria

Children less than 6 years and more than 10 years will be excluded.

Children with History of or presenting with Tuberculosis, COPD, emphysema, chronic airway limitation, severe upper airway obstruction or any anatomical defects of respiratory tract will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Parnayavani Arka Nebulization will help in reducing symptoms of broanchial asthma which will be assessed by GINA scale with me.Timepoint: First 3 days <br/ ><br>5th Day <br/ ><br>7th Day
Secondary Outcome Measures
NameTimeMethod
Tamboola arka nebulisation was proved to be effective in treating symptoms of broanchial asthma so it will reduce the symptoms of broanchiel asthma.Timepoint: First 3 days <br/ ><br>5th Day <br/ ><br>7th Day
© Copyright 2025. All Rights Reserved by MedPath